×
S&P 500   3,802.97 (-0.49%)
DOW   30,923.97 (-0.07%)
QQQ   283.66 (+0.04%)
AAPL   139.82 (+1.73%)
MSFT   259.97 (+1.36%)
META   163.94 (+2.03%)
GOOGL   2,236.67 (-0.16%)
AMZN   109.46 (+1.92%)
TSLA   674.11 (-3.42%)
NVDA   154.62 (-3.25%)
NIO   21.48 (-3.94%)
BABA   115.90 (-0.74%)
AMD   77.06 (-4.61%)
MU   55.80 (-3.56%)
CGC   3.54 (-1.94%)
T   20.79 (+0.87%)
GE   64.14 (-2.64%)
F   11.52 (-2.46%)
DIS   95.34 (-0.60%)
AMC   13.38 (-0.15%)
PFE   51.09 (+0.85%)
PYPL   71.32 (-0.70%)
NFLX   177.43 (-1.21%)
S&P 500   3,802.97 (-0.49%)
DOW   30,923.97 (-0.07%)
QQQ   283.66 (+0.04%)
AAPL   139.82 (+1.73%)
MSFT   259.97 (+1.36%)
META   163.94 (+2.03%)
GOOGL   2,236.67 (-0.16%)
AMZN   109.46 (+1.92%)
TSLA   674.11 (-3.42%)
NVDA   154.62 (-3.25%)
NIO   21.48 (-3.94%)
BABA   115.90 (-0.74%)
AMD   77.06 (-4.61%)
MU   55.80 (-3.56%)
CGC   3.54 (-1.94%)
T   20.79 (+0.87%)
GE   64.14 (-2.64%)
F   11.52 (-2.46%)
DIS   95.34 (-0.60%)
AMC   13.38 (-0.15%)
PFE   51.09 (+0.85%)
PYPL   71.32 (-0.70%)
NFLX   177.43 (-1.21%)
S&P 500   3,802.97 (-0.49%)
DOW   30,923.97 (-0.07%)
QQQ   283.66 (+0.04%)
AAPL   139.82 (+1.73%)
MSFT   259.97 (+1.36%)
META   163.94 (+2.03%)
GOOGL   2,236.67 (-0.16%)
AMZN   109.46 (+1.92%)
TSLA   674.11 (-3.42%)
NVDA   154.62 (-3.25%)
NIO   21.48 (-3.94%)
BABA   115.90 (-0.74%)
AMD   77.06 (-4.61%)
MU   55.80 (-3.56%)
CGC   3.54 (-1.94%)
T   20.79 (+0.87%)
GE   64.14 (-2.64%)
F   11.52 (-2.46%)
DIS   95.34 (-0.60%)
AMC   13.38 (-0.15%)
PFE   51.09 (+0.85%)
PYPL   71.32 (-0.70%)
NFLX   177.43 (-1.21%)
S&P 500   3,802.97 (-0.49%)
DOW   30,923.97 (-0.07%)
QQQ   283.66 (+0.04%)
AAPL   139.82 (+1.73%)
MSFT   259.97 (+1.36%)
META   163.94 (+2.03%)
GOOGL   2,236.67 (-0.16%)
AMZN   109.46 (+1.92%)
TSLA   674.11 (-3.42%)
NVDA   154.62 (-3.25%)
NIO   21.48 (-3.94%)
BABA   115.90 (-0.74%)
AMD   77.06 (-4.61%)
MU   55.80 (-3.56%)
CGC   3.54 (-1.94%)
T   20.79 (+0.87%)
GE   64.14 (-2.64%)
F   11.52 (-2.46%)
DIS   95.34 (-0.60%)
AMC   13.38 (-0.15%)
PFE   51.09 (+0.85%)
PYPL   71.32 (-0.70%)
NFLX   177.43 (-1.21%)

Top 3 Safe Stocks for Conservative Investors

Friday, April 15, 2022 | Sean Sechler
Top 3 Safe Stocks for Conservative Investors

These Are Solid Stocks for Conservative Investors to Consider

It’s impossible to avoid risk entirely when you are investing in stocks, but there are definitely certain areas of the market that offer more safety and less volatility than others. Safer companies typically have consistent profitability over the years, strong competitive advantages, a lack of cyclicality, and a history of dividend growth. These slow and steady gainers can help you generate substantial returns over the long term without putting your portfolio at risk of massive drawdowns, which is why they are ideal for conservative investors.

Given how volatile equity markets have been in 2022, it makes a lot of sense to consider adding shares of stocks that are perceived to be “safe”. It just so happens that many of these lower volatility stocks have been outperforming the market, which tells us that investors are flocking to low-volatility investments at this time. If you need a reminder of the benefits of conservative stocks, take a look at just how far some of the leading growth stocks have fallen from grace.

That’s why we’ve put together the following list of the top 3 safe stocks for conservative investors. Let’s take a deeper look below.

Costco Wholesale (NASDAQ: COST)

When it comes to investing conservatively, finding businesses that are market leaders and that will be able to generate sizeable profits in any economic environment is usually the recipe for success. That’s why Costco Wholesale stands out as a safe pick. The membership warehouse giant had 815 stores worldwide at the end of its fiscal 2021 and offers investors a rock-solid business model that helps the company retain millions of loyal customers year after year. Part of what makes Costco so special is the way that the company concentrates its buying power on a select number of items, which in turn allows it to take advantage of purchasing leverage and pass on savings to members.

Costco shares have been outperforming in a big way over the last year, and although shares are richly valued at this time it’s still the ideal buy-the-dip stock for long-term investors. The company recently reported Q2 comparable sales growth of 14% and Q2 EPS growth of 36%, and although inflation could eat into operating margins it looks like another big earnings year is on the cards. Keep in mind that if the economy enters recession territory, more people will be looking to save on their everyday purchases by shopping at Costco, which makes this a safe stock amidst a lot of uncertainty.

Coca-Cola Co (NYSE: KO)

Consumer staples are a great area of the market to look at for safe stock picks, and Coca-Cola stands out as one of the strongest options in the sector. Shares of the beverage king are hitting new all-time highs in a mixed tape, which speaks volumes about why this is such a quality name to consider. As a leading producer of soda, juices, and ready-to-drink teas and coffees, investors can count on Coca-Cola to generate stable earnings quarter after quarter, which in turn helps the company support an attractive dividend payout. The stock currently offers a 2.72% dividend yield, while the company recently boosted its annual payout by roughly 5%.

Consistency is key for conservative investors, and the fact that Coca-Cola is a dividend king should particularly be reassuring. This is also a safe pick considering that the company is about 3 times as large as its next-largest competitor in terms of volume, which means it’s difficult to imagine Coca-Cola losing its market-leading position anytime soon. The bottom line here is that when volatility is on the rise and investors have unanswered questions about where the economy is heading, this stock tends to outperform, making it a great option for conservative investors to consider.

Pfizer (NYSE: PFE)

Biopharmaceutical companies like Pfizer are another fantastic option for conservative investors to consider, as it’s a company that generates over $50 billion in annual sales regardless of what’s going on in the world. Oncology and immunology drugs, treatments for rare diseases, and vaccines make up a diverse product portfolio that investors can count on for the long term, while Pfizer also offers some earnings growth potential given its promising pipeline of new drugs.

All of this adds up to a great pick for almost any portfolio, and with shares trading at an attractive 7.35x forward earnings, it’s hard to find many downsides to owning this company for the long term. Pfizer is also a safe pick thanks to the company’s 3.01% dividend yield and the fact that the company’s underperforming Upjohn business has been spun off. The company posted EPS growth of 96% in 2021 largely due to COVID-19 vaccine revenue, and if Pfizer reinvests a large portion of its earnings to make acquisitions and work on its pipeline it could lead to even more upside for long-term shareholders.

Costco Wholesale is a part of the Entrepreneur Index, which tracks some of the largest publicly traded companies founded and run by entrepreneurs.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Costco Wholesale (COST)
3.2498 of 5 stars
$471.10+0.5%0.76%37.09Moderate Buy$569.56
Pfizer (PFE)
3.2431 of 5 stars
$51.12+0.9%3.13%11.72Moderate Buy$57.26
Coca-Cola (KO)
2.8295 of 5 stars
$62.85+0.9%2.80%26.41Moderate Buy$68.05
Compare These Stocks  Add These Stocks to My Watchlist 

Should you invest $1,000 in Costco Wholesale right now?

Before you consider Costco Wholesale, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Costco Wholesale wasn't on the list.

While Costco Wholesale currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:


Most Read This Week

Recent Articles

Search Headlines:

Latest PodcastHow to Profit In The Bear Market

Today, Kate is joined by a repeat guest, Rob Isbitts of Sungarden Investment Publishing. Rob specializes in ETF portfolios designed to deliver returns in any kind of market condition, including the current bear. In this conversation, Rob gives specific ideas for handling various allocations in your portfolio, and discusses how to approach inverse ETFs.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.